Home LiteratureArticle Details
PMID: 19744321 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.

BMC microbiology ·Vol. 9 ·2009-09-10 ·Pages 194

Damy SB, Higuchi ML, Timenetsky J, Reis MM, Palomino SP, Ikegami RN, Santos FP, Osaka JT, Figueiredo LP

Abstract

Chamydophila pneumoniae (CP) and/or Mycoplasma pneumoniae (MP) are two bacteria detected in vulnerable atheromas. In this study we aimed to analyze whether CP and/or MP aggravates atherosclerosis induced by cholesterol-enriched diet in C57BL/6 apoE KO male mice. Thirty male apoE KO mice aged eight weeks fed by a diet containing 1% cholesterol until 32 weeks of age were divided into four groups: the first was inoculated with CP (n = 7), the second with MP (n = 12), the third with both CP + MP (n = 5), and the fourth with saline (sham n = 6). The animals were re-inoculated at 36 weeks of age, and sacrificed at 40 weeks of age. Two ascending aorta and one aortic arch segments were sampled. In the most severely obstructed segment, vessel diameter, plaque height, percentage of luminal obstruction and the degree of adventitial inflammation were analyzed. The plaque area/intimal surface ratio was obtained by measuring all three segments. The adventitial inflammation was semiquantified (0 absent, 1 mild, 2 moderate, and 3 diffuse). The mean and standard deviation of plaque height, % luminal obstruction, external diameter, the plaque area/intimal surface ratio and the adventitial inflammation values are the following for each group: MP (0.20 +/- 0.12 mm, 69 +/- 26%, 0.38 +/- 0.11 mm, 0.04 +/- 0.04 and 0.22 +/- 0.67), CP (0.23 +/- 0.08 mm, 90 +/- 26%, 0.37 +/- 0.08 mm, 0.04 +/- 0.03, and 0.44 +/- 0.53), MP + CP (18 +/- 0.08 mm, 84 +/- 4.0%, 0.35 +/- 0.25 mm, 0.03 +/- 0.03 and 1.33 +/- 0.82) and sham (0.08 +/- 0.09 mm, 42 +/- 46%, 0.30 +/- 0.10 mm, 0.02 +/- 0.03 and 0.71 +/- 0.76). A wider area of plaque/intimal surface was observed in MP + CP inoculated groups (p = 0.07 and 0.06) as well as an increased plaque height in CP (p = 0.01) in comparison with sham group. There was also an increased luminal obstruction (p = 0.047) in CP inoculated group in comparison to sham group. Adventitial inflammation in MP + CP inoculated group was higher than MP, CP and the sham groups (p = 0.02). Inoculation of CP, MP or both agents in C57BL/6 apoE KO male mice caused aggravation of experimental atherosclerosis induced by cholesterol-enriched diet, with distinct characteristics. CP inoculation increased the plaque height with positive vessel remodeling and co-inoculation of MP + CP caused the highest adventitial inflammation measures.

MeSH Terms
Animals Aorta/microbiology,pathology Aortic Diseases/complications,microbiology Atherosclerosis/complications,microbiology Chlamydophila Infections/complications Chlamydophila pneumoniae Cholesterol, Dietary Male Mice Mice, Inbred C57BL Mice, Knockout Mycoplasma pneumoniae Pneumonia, Mycoplasma/complications
Chemicals
Cholesterol, Dietary
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Damy Sueli B
Heart Institute (InCor) of Clinical Hospital, University of Sao Paulo, Sao Paulo, Brazil. [email protected]
Higuchi Maria L
Timenetsky Jorge
Reis Márcia M
Palomino Suely P
Ikegami Renata N
Santos Fabiana P
Osaka Junko T
Figueiredo Luiz P
References (37)
37 references, click to expand
  1. Growth of the alveoli and pulmonary arteries in childhood.
    Thorax. 1970 Nov;25(6):669-81 PMID: 5533319
  2. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.
    Cardiovasc Res. 2005 Feb 1;65(2):317-27 PMID: 15639470
  3. Molecular biology and pathogenicity of mycoplasmas.
    Microbiol Mol Biol Rev. 1998 Dec;62(4):1094-156 PMID: 9841667
  4. A role for archaeal organisms in development of atherosclerotic vulnerable plaques and myxoid matrices.
    Clinics (Sao Paulo). 2006 Oct;61(5):473-8 PMID: 17072447
  5. Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction.
    Arq Bras Cardiol. 2003 Jul;81(1):12-22, 1-11 PMID: 12908069
  6. Infection and early atherosclerosis: does the evidence support causation?
    Acta Paediatr. 2005 Jun;94(6):643-51 PMID: 16188762
  7. Impact of infectious burden on progression of carotid atherosclerosis.
    Stroke. 2002 Nov;33(11):2581-6 PMID: 12411646
  8. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease.
    Circulation. 2006 Feb 21;113(7):929-37 PMID: 16490835
  9. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae in different forms of coronary disease.
    Arq Bras Cardiol. 2009 Jun;92(6):405-11, 422-8, 439-45 PMID: 19629306
  10. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.
    J Lipid Res. 2004 Jul;45(7):1169-96 PMID: 15102878
  11. Bacteria and coronary atheroma: more fingerprints but no smoking gun.
    Circulation. 2006 Feb 21;113(7):920-2 PMID: 16490832
  12. Inflammation and atherosclerosis.
    Circulation. 2002 Mar 5;105(9):1135-43 PMID: 11877368
  13. Evolution of species interactions in a biofilm community.
    Nature. 2007 Feb 1;445(7127):533-6 PMID: 17268468
  14. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.
    J Cell Biol. 1963 Apr;17:208-12 PMID: 13986422
  15. Chlamydia pneumoniae and coronary artery disease: controversial results of serological studies.
    Int Immunopharmacol. 2006 Sep;6(9):1524-5 PMID: 16846847
  16. Association of common chronic infections with coronary artery disease in patients without any conventional risk factors.
    Indian J Med Res. 2007 Feb;125(2):129-36 PMID: 17431281
  17. Effect of diets on lipoprotein concentrations in heterozygous apolipoprotein E-deficient mice.
    Physiol Res. 2004;53(6):635-43 PMID: 15588132
  18. Association of Mycoplasma pneumoniae infection with coronary artery disease and its interaction with chlamydial infection.
    Atherosclerosis. 2004 Sep;176(1):139-44 PMID: 15306186
  19. How should we define inadequate coronary arterial remodeling?
    Circulation. 1998 Apr 14;97(14):1424-5 PMID: 9577957
  20. Coinfection of laboratory rats with Mycoplasma pulmonis and Chlamydia pneumoniae.
    Contemp Top Lab Anim Sci. 2003 Jan;42(1):52-6 PMID: 12580575
  21. Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques.
    Braz J Med Biol Res. 2000 Sep;33(9):1023-6 PMID: 10973132
  22. Mycoplasma infections of the human respiratory tract.
    Wien Klin Wochenschr. 1997 Aug 8;109(14-15):574-7 PMID: 9286062
  23. Identification of nine species of the Chlamydiaceae using PCR-RFLP.
    Int J Syst Bacteriol. 1999 Apr;49 Pt 2:803-13 PMID: 10319506
  24. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression.
    Circulation. 1998 Jul 28;98(4):300-7 PMID: 9711934
  25. Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions.
    J Infect Dis. 2000 Jun;181 Suppl 3:S483-9 PMID: 10839744
  26. Long-term survival and intracellular replication of Mycoplasma hominis in Trichomonas vaginalis cells: potential role of the protozoon in transmitting bacterial infection.
    Infect Immun. 2005 Feb;73(2):1180-6 PMID: 15664961
  27. De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model.
    Infect Immun. 1999 Nov;67(11):6048-55 PMID: 10531266
  28. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.
    BMJ. 2000 Jul 22;321(7255):208-13 PMID: 10903653
  29. Potential infectious etiologies of atherosclerosis: a multifactorial perspective.
    Emerg Infect Dis. 2001 Sep-Oct;7(5):780-8 PMID: 11747688
  30. Production of prostaglandin E2 in monocytes stimulated in vitro by Chlamydia trachomatis, Chlamydophila pneumoniae, and Mycoplasma fermentans.
    Microb Pathog. 2004 Sep;37(3):155-61 PMID: 15351039
  31. Compensatory enlargement of human atherosclerotic coronary arteries.
    N Engl J Med. 1987 May 28;316(22):1371-5 PMID: 3574413
  32. The chlamydial inclusion: escape from the endocytic pathway.
    Annu Rev Cell Dev Biol. 2002;18:221-45 PMID: 12142274
  33. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role?
    FEMS Microbiol Lett. 2001 Apr 1;197(1):1-9 PMID: 11287138
  34. Mouse models of experimental atherosclerosis.
    J Physiol Pharmacol. 2004 Sep;55(3):503-17 PMID: 15381823
  35. Co-infection ratios versus inflammation, growth factors and progression of early atheromas.
    APMIS. 2006 May;114(5):338-44 PMID: 16725009
  36. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    J Infect Dis. 1999 Jul;180(1):238-41 PMID: 10353889
  37. Severity of carotid atherosclerosis unrelated to Chlamydia pneumoniae infection in acute ischemic stroke patients: a clinicopathological study.
    Cerebrovasc Dis. 2008;25(1-2):170-5 PMID: 18212523
Article Info
Journal
BMC microbiology
Abbr.
BMC Microbiol
ISSN
1471-2180
Published
2009-09-10
Epub
2009-00-10
Pages
194
Language
English
Region
England
NLM ID
100966981
PMCID
PMC2755007
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]